Close
Lecture
series event

Pneumococcal conjugate vaccine: new approaches to measuring impact

Following the introduction of the vaccine in Fiji, fewer people in the community carried the vaccinated types of pneumococcus. Picture: Australian High Commission, Suva
Following the introduction of the vaccine in Fiji, fewer people in the community carried the vaccinated types of pneumococcus. Picture: Australian High Commission, Suva

Hosted by the LSHTM Vaccine Centre, hear from Professor Fiona Russell a visiting academic from The University of Melbourne who leads a number of research studies in the Pacific and has extensive experience working in the region. She will talk about her work on pneumococcal vaccines “Pneumococcal conjugate vaccine: new approaches to measuring impact”.

 

Prof Fiona Russell is a paediatrician with an interest in translation. She is Director of the Child and Adolescent Health PhD Program, Department of Paediatrics, The University of Melbourne; and Group Leader for the Asia-Pacific Health research group at the Murdoch Children’s Research Institute, Melbourne, Australia. Her research provides evidence for policy and clinical practice to improve child health outcomes in low-income countries, especially related to infectious diseases. Her PhD focussed on reduced dose PCV schedules and she is now evaluating the impact of pneumococcal conjugate and rotavirus vaccines, and a single dose HPV vaccine schedule in various Asia-Pacific countries. She leads Bill & Melinda Gates funded studies using novel approaches to show evidence of impact and further understand pneumococcal transmission. She leads a clinical trial of Azithromycin in labour to prevent maternal and infant infections in Fiji. In 2019, she was awarded the Australasian Society of Infectious Diseases Frank Fenner Award.

 

Please note that this session will  NOT be live-streamed/recorded.

Admission

Admission
No registration required. Seats available on first come, first served basis.

Contact

Contact